Tirzepatide

A dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes. Clinical trials show significant weight reduction, often exceeding semaglutide results.

Details

Category
weight-loss
Administration
Subcutaneous injection (weekly)
Prescription Required
Yes
Also known as
Mounjaro, Zepbound

Common Uses